BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25169781)

  • 1. Positron emission tomography-positive thyroid nodules: rate of malignancy and histological features.
    Flukes S; Lenzo N; Moschilla G; Sader C
    ANZ J Surg; 2016 Jun; 86(6):487-91. PubMed ID: 25169781
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
    J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
    Yerubandi V; Chin BB; Sosa JA; Hoang JK
    AJR Am J Roentgenol; 2016 Feb; 206(2):420-5. PubMed ID: 26797373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
    Adas M; Adas G; Koc B; Ozulker F
    Minerva Endocrinol; 2015 Sep; 40(3):169-75. PubMed ID: 26205646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by
    Suh CH; Choi YJ; Lee JJ; Shim WH; Baek JH; Chung HC; Shong YK; Song DE; Sung TY; Lee JH
    Thyroid; 2017 Oct; 27(10):1258-1266. PubMed ID: 28791924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Traugott AL; Dehdashti F; Trinkaus K; Cohen M; Fialkowski E; Quayle F; Hussain H; Davila R; Ylagan L; Moley JF
    World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound stratification of the FDG-avid thyroid nodule.
    Beech P; Lavender I; Jong I; Soo G; Ramdave S; Chong A; Nandurkar D
    Clin Radiol; 2016 Feb; 71(2):164-9. PubMed ID: 26683088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.
    Are C; Hsu JF; Ghossein RA; Schoder H; Shah JP; Shaha AR
    Ann Surg Oncol; 2007 Nov; 14(11):3210-5. PubMed ID: 17713821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology.
    Giovanella L; Suriano S; Maffioli M; Ceriani L
    Clin Endocrinol (Oxf); 2011 May; 74(5):644-8. PubMed ID: 21470288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
    Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
    Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
    Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
    Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
    Sager S; Vatankulu B; Erdogan E; Mut S; Teksoz S; Ozturk T; Sonmezoglu K; Kanmaz B
    Endocrine; 2015 Sep; 50(1):138-45. PubMed ID: 25795290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidentally detected 18 F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
    Owens C; Fitzhugh A; Harrington K; Paleri V; Sharma B; Shur J; Ap Dafydd D
    Nucl Med Commun; 2023 Sep; 44(9):810-815. PubMed ID: 37272278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Hales NW; Krempl GA; Medina JE
    Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Thyroid Incidentalomas on
    de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
    Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.